Bioorganic and Medicinal Chemistry Letters p. 3029 - 3034 (1996)
Update date:2022-07-29
Topics:
Veenstra, Siem J.
Hauser, Kathleen
Schilling, Walter
Betschart, Claudia
Ofner, Silvio
CGP 49823 is a potent NK1 antagonist which is centrally active after oral administration. The SAR of the C-2 substituent was investigated with respect to the affinity to the NK1 receptor. A practical synthesis of CGP 49823, suitable for scale-up, was developed. The key-step, a tandem acyliminium ion cyclization/Ritter reaction, gave trans-2-benzyl-4-acetamido-piperidines with high diastereoselectivity.
View MoreShanghai ZaiQi Bio-Tech Co., Ltd.,
Contact:+86-21-5482 4098
Address:Bldg. No.7, No.201 MinYi Rd，Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
SHANDONG QINGYUNCHANGXIN CHEMICAL SCIENCE-TECH CO.,LTD
Contact:86-21-60560171
Address:1689Donghuan Rade,Qingyun County, Dezhou City, Shandong,China
Contact:86-510-82853889
Address:Rm.3732, No.18-2,Yonghe Rd.,Wuxi,Jiangsu,214023,China
Changzhou Screw International Trading Co., Ltd.
Contact:13906149256,18001495888
Address:Jiangsu，Jintanqu
ShanDong XinDa Chemical CO.,LTD(expird)
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
Doi:10.1021/jo961781i
(1997)Doi:10.1016/S0960-894X(97)00008-5
(1997)Doi:10.1002/jhet.5570330626
(1996)Doi:10.1021/ja01077a028
(1964)Doi:10.1248/cpb.45.53
(1997)Doi:10.1021/ja01101a038
(1953)
